The reality of LAMAs for adult asthmatic patients.

Author: AguiarRita, LuzMaria Inês, Morais-AlmeidaMário

Paper Details 
Original Abstract of the Article :
The use of tiotropium is approved for the treatment of asthma. There are several studies completed or currently ongoing with the long-acting muscarinic antagonists (LAMAs) umeclidinium and glycopyrronium as an add-on asthma treatment. Adding a second bronchodilator with a different mechanism of acti...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1080/17476348.2020.1794828

データ提供:米国国立医学図書館(NLM)

LAMAs for Asthma: A New Frontier in Treatment Options

The search for effective and safe treatments for [asthma] continues as researchers strive to improve patient outcomes and quality of life. This article discusses the use of [long-acting muscarinic antagonists (LAMAs)] in treating asthma, exploring the potential benefits and challenges of these medications.

LAMAs: Expanding the Arsenal for Asthma Management

The article highlights the growing interest in LAMAs as add-on therapy for asthma, particularly for patients who do not achieve adequate control with traditional treatments. The use of LAMAs, with their distinct mechanism of action, offers a potentially valuable approach for improving asthma management.

Navigating the Landscape of Asthma Treatment: LAMAs Offer a New Path

This article provides a valuable overview of the current landscape of LAMA use in asthma, discussing the evidence supporting their potential benefits and the ongoing research to address remaining questions. It underscores the need for individualized patient assessment and careful consideration of risks and benefits when incorporating LAMAs into treatment plans.

Dr. Camel's Conclusion

Like a seasoned explorer venturing into uncharted desert territories, researchers are exploring the potential of LAMAs as a new frontier in asthma treatment. This article provides a comprehensive view of the current landscape, highlighting the promising benefits and the ongoing research to navigate the challenges associated with this innovative approach.

Date :
  1. Date Completed 2021-06-14
  2. Date Revised 2021-06-14
Further Info :

Pubmed ID

32687426

DOI: Digital Object Identifier

10.1080/17476348.2020.1794828

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.